Send to printer »

GEN News Highlights : Mar 15, 2007

Pfizer Animal Health Gains Access to Crucell’s PER.C6

Cell line will be used in vaccine production.

Crucell and Pfizer Animal Health signed  a research license agreement for PER.C6®. The deal allows Pfizer Animal Health to use the cell technology in the production of a undisclosed veterinary vaccine.

Pfizer Animal Health has an option to convert the research license into a commercial agreement.